Which has the lower trailing P/E, ACAD or ICUI?

ACAD has the lower trailing P/E: ACAD trades at 8.92 and ICUI at 134.55. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ACAD or ICUI?

Over the past five years, ACAD grew revenue faster — ACAD at a 19.70% CAGR versus ICUI at 11.05%.

Is ACAD or ICUI more profitable?

ACAD runs the higher net margin — ACAD at 33.42% versus ICUI at 1.39%.

How have ACAD and ICUI total returns compared?

Over the past 10 years, ACAD delivered -3.53% and ICUI delivered 2.51% annualized total return. Past performance doesn't predict future results.

Acadia Pharmaceuticals Inc. (ACAD) vs ICU Medical, Inc. (ICUI)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and ICU Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACAD

Acadia Pharmaceuticals Inc.

$3.39B

$19.81HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

ICUI

ICU Medical, Inc.

$3.97B

$158.77HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT

Total return — ACAD vs ICUI

growth of $100 · dividends reinvested · last 10y

ACAD -26.1% (-3.0%/yr)ICUI +28.4% (+2.5%/yr)ICUI compounded faster over this window

ACAD ICUI

ACAD vs ICUI: by the numbers

•ICUI is the larger company ($3.97B vs $3.39B market cap).
•ACAD trades at the lower trailing earnings multiple (8.92 vs 134.55 P/E), one valuation lens rather than an overall verdict.
•ACAD converts more revenue to profit (33.42% vs 1.39% net margin).
•ACAD grew revenue faster over the past five years (19.70% vs 11.05% CAGR).

Metrics side by side

Valuation

Metric	ACAD	ICUI
P/E ratio	8.92	134.55
Forward P/E	32.15	N/A
P/S ratio	2.98	1.84
P/B ratio	2.60	1.84
EV / EBITDA	31.31	13.59
FCF yield	5.14%	3.85%

Profitability

Metric	ACAD	ICUI
Gross margin	91.13%	37.56%
Operating margin	7.59%	5.04%
Net margin	33.42%	1.39%
ROE	29.12%	1.40%
ROIC	6.25%	3.11%

Growth (annualized)

Metric	ACAD	ICUI
Revenue CAGR (5Y)	19.70%	11.05%
EPS CAGR (5Y)	N/A	-62.79%
FCF CAGR (5Y)	N/A	-2.65%
Total return CAGR (5Y)	3.52%	-7.18%

Frequently asked

Which has the lower trailing P/E, ACAD or ICUI?: ACAD has the lower trailing P/E: ACAD trades at 8.92 and ICUI at 134.55. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ACAD or ICUI?: Over the past five years, ACAD grew revenue faster — ACAD at a 19.70% CAGR versus ICUI at 11.05%.
Is ACAD or ICUI more profitable?: ACAD runs the higher net margin — ACAD at 33.42% versus ICUI at 1.39%.
How have ACAD and ICUI total returns compared?: Over the past 10 years, ACAD delivered -3.53% and ICUI delivered 2.51% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACAD analysis Full ICUI analysis Interactive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratio ICU Medical P/E ratio Acadia Pharmaceuticals ROE ICU Medical ROE Acadia Pharmaceuticals operating margin ICU Medical operating margin Acadia Pharmaceuticals revenue growth ICU Medical revenue growth Acadia Pharmaceuticals free cash flow ICU Medical free cash flow

Acadia Pharmaceuticals & ICU Medical appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.